Privately-held Italian drugmaker Chiesi Farmaceutici has appointed Alessandro Chiesi as chairman of the Chiesi Group. Additionally, it said that Maria Paola Chiesi becomes vice chair.
Alessandro Chiesi began his journey in the company nearly thirty years ago, starting in the mergers and acquisitions (M&A) sector and then taking on increasing responsibilities in overseeing European and global business activities. He has developed a successful and passionate team capable of building a sustainable business and establishing a trusted presence for our patients.
Maria Paola Chiesi joined the company in 1995. She gave an international dimension to marketing and charted the group’s strategic planning path. In 2015 she created and led the Shared Value & Sustainability department, which monitors and measures the company’s impacts on the environment and society, implementing improvement plans. As a result of this work, Chiesi changed its bylaws becoming a Benefit Corporation and obtained the B Corp certification. She is also the president of the Chiesi Foundation.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze